InvestorsHub Logo
Followers 26
Posts 1553
Boards Moderated 0
Alias Born 02/06/2003

Re: Eddie2468 post# 2967

Monday, 05/05/2014 9:59:24 PM

Monday, May 05, 2014 9:59:24 PM

Post# of 6477
Yes, my 20c bet re the registration filing looks gravely at risk but I'm not letting anybody claw it out of my hand until I see an actual filing :)

Re T&T: Seems obvious that you'd rather have the right to convert at VWAP rather than at a fixed $0.367, when the VWAP is currently well below that fixed level?

Anyway, really need to see the entire agreement to work out what's going on. If they do get a registration statement accepted, I think the agt will be attached to it; presumably it would be material enough for that.

Re the science work: I think clearly the goal should be to get a credible strategic pharma partner & doing so would go a long way to validating everything. I have no idea how likely that is or how much progress they would need to make before it becomes a realistic prospect.

For the peptide stuff, they still haven't gotten past the pre-clinical animal work; now saying it should be completed by 4th quarter. If you go back over their filings, they've been estimating "a few more months" to do this, for years. Maybe they'll actually get it done, finally. But if they rely on the Dutchess "financing" for it, they'll obviously have to do something to increase trading volumes. Will be interesting to watch.

One fundamental question: Assuming that Newell-Rogers is crucial to the work, how much time is she spending on it, given her demanding-sounding day job?